John DiPersio
4Patents
1h-index
8Co-inventors
33Inventor score
Filing activity: Aug 3, 2017 → May 17, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11696926B2 | Methods and compositions for treatment of cancer | Human Necessities | 1 | Active |
| US12350349B2 | Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors | Chemistry; Metallurgy | 0 | Active |
| US11597917B2 | In vitro and in vivo enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders | Chemistry; Metallurgy | 0 | Active |
| US12304941B2 | Suppression of cytokine release syndrome in chimeric antigen receptor cell therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.